Transcriptional upregulation of MAPK15 by NF-κB signaling boosts the efficacy of combination therapy with cisplatin and TNF-α

The efficacy of cisplatin in treating advanced non-small cell lung cancer is limited mainly because of insensitivity and/or acquired resistance. MAPK15, previously shown by us to enhance the sensitivity of the anti-cancer drug arsenic trioxide, could also enhance the sensitivity of other anti-cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dan-Dan, Dai, Li-Juan, Tan, Heng Wee, Zhao, Xiao-Yun, Wei, Qi-Yao, Zhong, Qiu-Hua, Ji, Yan-Chen, Yin, Xiao-Hui, Yu, Fei-Yuan, Jin, Dong-Yan, Li, Sheng-Qing, Lau, Andy T.Y., Xu, Yan-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678736/
https://www.ncbi.nlm.nih.gov/pubmed/36425765
http://dx.doi.org/10.1016/j.isci.2022.105459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678736/
https://www.ncbi.nlm.nih.gov/pubmed/36425765
http://dx.doi.org/10.1016/j.isci.2022.105459

Ejemplares similares